EU, India Pharmaceutical Trade
Tags: COMPLAINTS (Administrative procedure); WORLD Trade Organization; EUROPEAN Union; PHARMACEUTICAL industry; PATENT laws & legislation; GENERIC drugs
Related Articles
- Legal And Regulatory Update. // Journal of Commercial Biotechnology;Apr2010, Vol. 16 Issue 2, p174
The article presents updates related to patent regulations of the European Union (EU). In its final report on the Pharmaceutical Sector Inquiry, the European Commission expressed its concerns regarding patent settlement agreements between originator and generic companies, and the report stated...
- Patent expirations spell big changes for generic industry. Cassell, Dana K. // Drug Topics;8/6/2001 Supplement, Vol. 145 Issue 15, p9
Focuses on the increase of patent expirations among pharmaceutical industries in the United States. List of top eight drugs going off patent before December 2005; Delay of patent expiration due to court trials; Plan of an educational campaign on safety and efficacy of generic drugs.
- No deal in sight on cheap drugs for poor countries. Fleck, Fiona // BMJ: British Medical Journal (International Edition);3/1/2003, Vol. 326 Issue 7387, p465
Reports that trade talks in the World Trade Organization broke down after the United States, under pressure from its pharmaceutical lobby, rejected revised proposals to give poorer nations access to cheap, life-saving drugs. Drugs needed to save people in developing countries with illnesses...
- Trade Pact Weakens Patent Protections. Wechsler, Jill // Pharmaceutical Executive;Dec2001, Vol. 21 Issue 12, p24
Focuses on the impact on pharmaceutical companies of the World Trade Organization's decision to allow nations to override patent laws in 2001. Purpose of the decision; Details of the Trade-Related Aspects of Intellectual Property declaration; Implication of the decision for poor countries.
- Third World to receive generic drugs. // Pharmaceutical Technology Europe;Jan2006, Vol. 18 Issue 1, p10
The article reports that on the basis of an amendment in the regulations of the World Trade Organization (WTO), generic drugs would be allowed to be imported into developing countries for the treatment of serious diseases and epidemics. This amendment will make the temporary waiver to the...
- Health priorities gain patent reprieve for developing countries. Cherry, Michael // Nature;11/22/2001, Vol. 414 Issue 6862, p385
Reports the move of the World Trade Organization (WTO) on issues pertaining to patent laws on generic drugs in Doha, Qatar. Agreement of WTO regarding the use of medicine patent laws; Provisions of the trade-related aspects of intellectual property agreement; View of senior policy adviser to...
- Generic Pharmaceuticals: IP's Fiercest Litigation Arena. Andersen, Steven // Corporate Legal Times;Nov2003, Vol. 13 Issue 144, p28
Focuses on the complications in the generic drug application for patent rights by pharmaceutical companies in the U.S. Employment of strategy to extend the patent life of their products; Impact of the emergence of generic drugs on the pharmaceutical companies; Overview of the process of the...
- Patent Challenges. J. W. // Pharmaceutical Executive;Jun2007, Vol. 27 Issue 6, p24
The article reports that Thailand Government and other third-world nations are challenging patents on critical therapies, a tactic that is stepping up into a serious international confrontation over intellectual property protection. Thailand has been trying to override drug patents on AIDS...
- Court dismisses Novartis challenge to Indian patent law. Mudur, Ganapati // BMJ: British Medical Journal (International Edition);8/11/2007, Vol. 335 Issue 7614, p273
This article reports on a court ruling on patent law which went against drug company Novartis in India. Novartis was challenging the Indian law that prohibits patents on new forms or new uses of existing medications saying it was a violation of the Indian constitution and does not meet...
